相关实验视频

Updated: Jun 29, 2025

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
05:57

Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues

Published on: May 30, 2025

117

在患有晚期食道状细胞癌的患者中,tislelizumab诱导双器官功能障碍:一个病例报告

Bo Yang1, Wei Gou1, Naiying Lan1

  • 1Internal Medicine III (Nephrology), Naval Medical Center of PLA, Naval Medical University, Shanghai, China.

Frontiers in oncology
|March 29, 2024
PubMed
概括

抗PD-1抗体的tislelizumab可以在某些患者中引起严重的肝脏和脏损伤. 密切监测对于在癌症治疗期间管理这些与免疫相关的不良事件至关重要.

关键词:
急性脏损伤急性脏损伤急性肝损伤是什么?食管状细胞癌的癌症免疫检查点抑制剂免疫检查点抑制剂这样一来,我们就有了Tislelizumab.

更多相关视频

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

19.9K
ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection05:57

ADSC-sheet Transplantation to Prevent Stricture after Extended Esophageal Endoscopic Submucosal Dissection

Published on: February 10, 2017

8.5K

相关概念视频

Barrett Esophagus-II: Clinical Manifestations and Management01:21

Barrett Esophagus-II: Clinical Manifestations and Management

Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
141